Suppr超能文献

痤疮与皮肤微生物群:机制及治疗意义的系统评价

Acne and the cutaneous microbiome: A systematic review of mechanisms and implications for treatments.

作者信息

Podwojniak Alicia, Tan Isabella J, Sauer John, Neubauer Zachary, Rothenberg Hanna, Ghani Hira, Parikh Aarushi K, Cohen Bernard

机构信息

Rowan-Virtua School of Osteopathic Medicine, Stratford, New Jersey, USA.

Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

出版信息

J Eur Acad Dermatol Venereol. 2025 Apr;39(4):793-805. doi: 10.1111/jdv.20332. Epub 2024 Sep 13.

Abstract

BACKGROUND

Acne vulgaris is a pervasive skin disease characterized by inflammation of sebaceous units surrounding hair follicles. It results from the complex interplay between skin physiology and the intricate cutaneous microbiome. Current acne treatments, while effective, have major limitations, prompting a shift towards microbiome-based therapeutic approaches.

OBJECTIVES

This study aims to determine the relationship between acne and the cutaneous microbiome, assess the effects of current treatments on the cutaneous microbiome, and explore the implications for developing new therapies.

METHODS

A systematic review was performed using PubMed and SCOPUS databases within the last 10 years. Methodological quality was assessed independently by two authors. The search retrieved 1830 records, of which 26 articles met the inclusion criteria. Meta-analysis of alpha diversity change was assessed using fixed and randomized effect models per therapeutic group.

RESULTS

Eight studies pertain to the role of the cutaneous microbiome in acne, identifying C. acnes, S. aureus and S. epidermidis as key contributors through overproliferation, commensalism, or dysbiosis. Eleven studies discuss current acne treatments, including doxycycline (1), topical benzoyl peroxide (BPO) (4), isotretinoin (2), sulfacetamide-sulfur (SSA) (2) and aminolevulinic acid-photodynamic therapy (ALA-PDT) (2), identified as modulating the cutaneous microbiome as a mechanism of efficacy in acne treatment. Seven studies discuss new treatments with topical probiotics, plant derivatives, and protein derivatives, which contribute to acne clearance via modulation of dysbiosis, inflammatory markers and diversity indexes. A meta-analysis of the effects of existing therapeutics on the cutaneous microbiome identified benzoyl peroxide as the only treatment to facilitate significant change in diversity.

CONCLUSIONS

Despite the heterogeneity of study types and microbiome classifications limiting the analysis, this review underscores the complexity of microbial involvement in acne pathogenesis. It delineates the effects of acne therapeutics on microbial diversity, abundance, and composition, emphasizing the necessity for personalized approaches in acne management based on microbiome modulation.

摘要

背景

寻常痤疮是一种常见的皮肤病,其特征是毛囊周围皮脂腺单位发生炎症。它是皮肤生理学与复杂的皮肤微生物群之间复杂相互作用的结果。目前的痤疮治疗方法虽然有效,但有重大局限性,促使人们转向基于微生物群的治疗方法。

目的

本研究旨在确定痤疮与皮肤微生物群之间的关系,评估当前治疗方法对皮肤微生物群的影响,并探讨开发新疗法的意义。

方法

使用过去10年内的PubMed和SCOPUS数据库进行系统综述。由两位作者独立评估方法学质量。检索到1830条记录,其中26篇文章符合纳入标准。每个治疗组使用固定效应模型和随机效应模型评估α多样性变化的荟萃分析。

结果

八项研究涉及皮肤微生物群在痤疮中的作用,确定痤疮丙酸杆菌、金黄色葡萄球菌和表皮葡萄球菌是通过过度增殖、共生或生态失调成为关键因素。十一项研究讨论了当前的痤疮治疗方法,包括多西环素(1项)、外用过氧化苯甲酰(BPO)(4项)、异维A酸(2项)、磺胺醋酰钠-硫磺(SSA)(2项)和氨基乙酰丙酸-光动力疗法(ALA-PDT)(2项),这些治疗方法被确定为通过调节皮肤微生物群作为痤疮治疗疗效的一种机制。七项研究讨论了外用益生菌、植物衍生物和蛋白质衍生物的新治疗方法,这些方法通过调节生态失调、炎症标志物和多样性指数有助于清除痤疮。对现有治疗方法对皮肤微生物群影响的荟萃分析确定,过氧化苯甲酰是唯一能促进多样性显著变化的治疗方法。

结论

尽管研究类型和微生物群分类的异质性限制了分析,但本综述强调了微生物参与痤疮发病机制的复杂性。它描述了痤疮治疗方法对微生物多样性、丰度和组成的影响,强调了基于微生物群调节的痤疮个性化管理方法的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcd/11934012/62c558492b42/JDV-39-793-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验